Skip to main content
logo
Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
23.96
+0.30 (1.27%)
At close: May 8, 2026, 4:00 PM EDT
24.43
+0.47 (1.96%)
After-hours: May 8, 2026, 6:27 PM EDT

Alamar Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Revenue
74.2125.14
Revenue Growth (YoY)
195.17%-
Cost of Revenue
32.5116.54
Gross Profit
41.718.61
Selling, General & Admin
35.5718.94
Research & Development
37.4739.23
Total Operating Expenses
73.0458.18
Operating Income
-31.33-49.57
Interest Income
2.164.68
Interest Expense
-0.4-2.08
Other Non-Operating Income (Expense)
0.42-0.09
Total Non-Operating Income (Expense)
2.182.51
Pretax Income
-29.15-47.06
Provision for Income Taxes
0.670.01
Net Income
-29.82-46.27
Net Income to Common
-29.82-46.27
Shares Outstanding (Basic)
1211
Shares Outstanding (Diluted)
1212
Shares Change (YoY)
-2.89%-
EPS (Basic)
-2.58-4.40
EPS (Diluted)
-2.58-4.60
Shares Outstanding
12.5411.58
Free Cash Flow
-58.98-58.16
Free Cash Flow Per Share
-5.11-4.89
Gross Margin
56.20%34.23%
Operating Margin
-42.22%-197.15%
Profit Margin
-40.18%-187.23%
FCF Margin
-79.48%-231.33%
EBITDA
-27.47-46.37
EBITDA Margin
-37.02%-184.45%
EBIT
-31.33-49.57
EBIT Margin
-42.22%-197.15%
Effective Tax Rate
-2.28%-0.03%
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q